MFX
MFX provides the Cyto Engine to speed development and manufacturing of cell and gene therapies by combining precise bioprocessing with data-driven control. The platform pairs scalable, automated bioreactor hardware (including plug-and-play cassettes and microfluidics) with software for real-time monitoring, machine learning–based analysis, and visualization to enable bio-adaptive culture. MFX offers instrument variants for research (Development Engine), GMP-compliant manufacturing (Manufacturing Engine), and high-intensity production (Manufacturing Stack). The product is delivered as a SaaS-enabled bioprocessing platform integrating hardware and analytics for therapy developers and manufacturers. It targets the cell and gene therapy market to improve scale-up, process insight, and manufacturing control.
MFX
MFX provides the Cyto Engine to speed development and manufacturing of cell and gene therapies by combining precise bioprocessing with data-driven control. The platform pairs scalable, automated bioreactor hardware (including plug-and-play cassettes and microfluidics) with software for real-time monitoring, machine learning–based analysis, and visualization to enable bio-adaptive culture. MFX offers instrument variants for research (Development Engine), GMP-compliant manufacturing (Manufacturing Engine), and high-intensity production (Manufacturing Stack). The product is delivered as a SaaS-enabled bioprocessing platform integrating hardware and analytics for therapy developers and manufacturers. It targets the cell and gene therapy market to improve scale-up, process insight, and manufacturing control.